MOPRAL Side Effects

6778989-5 | Cytolytic Hepatitis
on Jun 09, 2010 Female patient from FRANCE , 59 years of age, was diagnosed with gastroduodenal ulcer, osteoarthritis (What is osteoarthritis?) and was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Mopral dosage: . During the same period patient was treated with ERYTHROMYCINE (View Erythromycine Review and Erythromycine Label ), DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

6762896-8 | Cytolytic Hepatitis
Patient was taking Mopral (View Usage). Patient had the following side effects: cytolytic hepatitis on May 26, 2010 from FRANCE Additional patient health information: Male patient , 89 years of age, . Mopral dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), SERESTA (View Seresta Review and Seresta Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DECAPEPTYL (View Decapeptyl Review and Decapeptyl Label ). Patient was hospitalized.

6755943-0 | Cytolytic Hepatitis
Adverse event was reported on May 26, 2010 by a Male patient taking Mopral (View Usage) (Dosage: ) . Location: FRANCE , 89 years of age, After Mopral was administered, patient had the following side effects: cytolytic hepatitis. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), SERESTA (View Seresta Review and Seresta Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), DECAPEPTYL (View Decapeptyl Review and Decapeptyl Label ). Patient was hospitalized.

6723324-1 | Leukocytosis, Lung Disorder, Platelet Count Increased, Pyrexia, Red Blood Cell Sedimentation Rate Increased
on May 04, 2010 Male patient from FRANCE , 15 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytosis, lung disorder, platelet count increased, pyrexia, red blood cell sedimentation rate increased. Mopral dosage: . During the same period patient was treated with METHOTREXATE (3 G/me2 5.34 G/course, 3 Week Cycles) (View Methotrexate Review and Methotrexate Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), LASIX (View Lasix Review and Lasix Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), BISEPTINE (View Biseptine Review and Biseptine Label ), AUREOMYCINE (3 Week Cycles) (View Aureomycine Review and Aureomycine Label ), GLUCOSE (View Glucose Review and Glucose Label ).


6692352-7 | Renal Failure Acute
on Apr 14, 2010 Male patient from FRANCE , 17 years of age, was diagnosed with osteosarcoma localised and was treated with Mopral (View Usage). Patient had the following side effects: renal failure acute. Mopral dosage: . During the same period patient was treated with VORAXAZE (View Voraxaze Review and Voraxaze Label ). Patient was hospitalized.

6631673-0 | Anuria, Diarrhoea, Renal Failure
Patient was taking Mopral (View Usage). After Mopral was administered, patient had the following side effects: anuria, diarrhoea, renal failure on Mar 08, 2010 from FRANCE Additional patient health information: Male patient , 45 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Mopral dosage: . During the same period patient was treated with METHOTREXATE (6g Once, Third Line, Third Course, 3000mg/m2) (View Methotrexate Review and Methotrexate Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.

6631664-X | Renal Failure Acute
Adverse event was reported on Mar 08, 2010 by a Male patient taking Mopral (View Usage) (Dosage: ) was diagnosed with bone sarcoma and. Location: FRANCE , 19 years of age, weighting 242.5 lb, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6527897-3 | Convulsion
on Dec 28, 2009 Female patient from FRANCE , 37 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, antiviral prophylaxis, anxiety (What is anxiety?), migraine (What is migraine?) and was treated with Mopral (View Usage). Patient had the following side effects: convulsion. Mopral dosage: . During the same period patient was treated with MUTAGRIP (View Mutagrip Review and Mutagrip Label ), LAROXYL (15 Drops / Day) (View Laroxyl Review and Laroxyl Label ), PROZAC (View Prozac Review and Prozac Label ), CIALIS (View Cialis Review and Cialis Label ), BI PROFENID (View Bi Profenid Review and Bi Profenid Label ). Patient was hospitalized.

6447212-3 | Agranulocytosis, Lymphadenitis, Neutropenia, Oral Fungal Infection, Pyrexia
on Nov 10, 2009 Female patient from FRANCE , 65 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, sciatica (What is sciatica?), hypertension and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: agranulocytosis, lymphadenitis, neutropenia, oral fungal infection, pyrexia. Mopral dosage: . During the same period patient was treated with FELDENE (View Feldene Review and Feldene Label ), MYOLASTAN (View Myolastan Review and Myolastan Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

6443057-9 | Personality Disorder, Suicidal Ideation
Patient was taking Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: personality disorder (What is personality disorder?), suicidal ideation on Nov 09, 2009 from FRANCE Additional patient health information: Male patient , 79 years of age, was diagnosed with abdominal pain upper and. Mopral dosage: . During the same period patient was treated with MODOPAR (View Modopar Review and Modopar Label ), TRIATEC (View Triatec Review and Triatec Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SERESTA (View Seresta Review and Seresta Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ).

6429024-X | Cholestasis, Cytolytic Hepatitis, Haemolytic Anaemia, Methaemoglobinaemia
Adverse event was reported on Oct 28, 2009 by a Female patient taking Mopral (View Usage) (Dosage: ) was diagnosed with dyslipidaemia, lupus-like syndrome, thrombosis prophylaxis and. Location: FRANCE , weighting 83.78 lb, Patient had the following side effects: cholestasis, cytolytic hepatitis, haemolytic anaemia, methaemoglobinaemia. During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), TAHOR (View Tahor Review and Tahor Label ), DAPSONE (View Dapsone Review and Dapsone Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6418260-4 | Convulsion
on Oct 19, 2009 Female patient from FRANCE , 37 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, influenza immunisation, anxiety (What is anxiety?), migraine (What is migraine?) and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: convulsion. Mopral dosage: . During the same period patient was treated with MUTAGRIP (View Mutagrip Review and Mutagrip Label ), LAROXYL (15 Drops / Day) (View Laroxyl Review and Laroxyl Label ), PROZAC (View Prozac Review and Prozac Label ), CIALIS (View Cialis Review and Cialis Label ), BI PROFENID (View Bi Profenid Review and Bi Profenid Label ). Patient was hospitalized.

6369796-6 | Inflammation, Pyrexia
on Sep 14, 2009 Female patient from FRANCE , weighting 105.8 lb, was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: inflammation, pyrexia. Mopral dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), NOVONORM (View Novonorm Review and Novonorm Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), FORLAX (View Forlax Review and Forlax Label ), PLAVIX (View Plavix Review and Plavix Label ), TRIATEC (View Triatec Review and Triatec Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6309202-0 | Cytolytic Hepatitis
Patient was taking Mopral (View Usage). Patient had the following side effects: cytolytic hepatitis on Aug 06, 2009 from FRANCE Additional patient health information: Male patient , 40 years of age, was diagnosed with gastrooesophageal reflux disease and. Mopral dosage: . Patient was hospitalized.

6304306-0 | Anaemia, Condition Aggravated, Thrombocytopenia
Adverse event was reported on Aug 03, 2009 by a Male patient taking Mopral (View Usage) (Dosage: ) . Location: FRANCE , 69 years of age, After Mopral was administered, patient had the following side effects: anaemia, condition aggravated, thrombocytopenia. During the same period patient was treated with EFIENT (View Efient Review and Efient Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), TAHOR (View Tahor Review and Tahor Label ), STILNOX (View Stilnox Review and Stilnox Label ), SKENAN (View Skenan Review and Skenan Label ), FORLAX (View Forlax Review and Forlax Label ), ACTISKENAN (View Actiskenan Review and Actiskenan Label ). Patient was hospitalized.

6293745-2 | Hypotension, Hypothermia, Somnolence
on Jul 23, 2009 Male patient from FRANCE , 40 years of age, was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, hypothermia (What is hypothermia?), somnolence. Mopral dosage: . During the same period patient was treated with ATARAX (View Atarax Review and Atarax Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), URBANYL (View Urbanyl Review and Urbanyl Label ), DEPAKENE (View Depakene Review and Depakene Label ), LAMICTAL (View Lamictal Review and Lamictal Label ).

6292517-2 | Azoospermia
on Jul 23, 2009 Male patient from FRANCE , 25 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Mopral (View Usage). Patient had the following side effects: azoospermia. Mopral dosage: .

6260225-X | Renal Failure
Patient was taking Mopral (View Usage). After Mopral was administered, patient had the following side effects: renal failure on Jul 01, 2009 from FRANCE Additional patient health information: Male patient , 59 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and. Mopral dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), GLUCOR (View Glucor Review and Glucor Label ), RISORDAN (View Risordan Review and Risordan Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

6236314-2 | Petit Mal Epilepsy
Adverse event was reported on Jun 12, 2009 by a Female patient taking Mopral (View Usage) (Dosage: ) was diagnosed with gastrooesophageal reflux disease, regurgitation and. Location: FRANCE , weighting 19.84 lb, Patient experienced the following unwanted or unexpected effects: petit mal epilepsy. During the same period patient was treated with GAVISCON (View Gaviscon Review and Gaviscon Label ), MOTILIUM (View Motilium Review and Motilium Label ). Patient was hospitalized.

6152725-8 | Dermatitis Exfoliative, Dermatomyositis, Pruritus
on Apr 07, 2009 Female patient from FRANCE , 79 years of age, was diagnosed with gastrointestinal injury, osteoarthritis (What is osteoarthritis?) and was treated with Mopral (View Usage). Patient had the following side effects: dermatitis exfoliative, dermatomyositis, pruritus. Mopral dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

6144389-4 | Blood Creatine Phosphokinase Increased, Hepatocellular Injury, Myalgia
on Mar 26, 2009 Male patient from FRANCE , weighting 176.4 lb, was diagnosed with abdominal pain upper and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: blood creatine phosphokinase increased, hepatocellular injury, myalgia. Mopral dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), STROMECTOL (View Stromectol Review and Stromectol Label ). Patient was hospitalized.

6128201-5 | Exophthalmos, Meningitis
Patient was taking Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: exophthalmos, meningitis (What is meningitis?) on Mar 12, 2009 from FRANCE Additional patient health information: Female patient , 15 years of age, was diagnosed with hiatus hernia and. Mopral dosage: . During the same period patient was treated with REVAXIS (View Revaxis Review and Revaxis Label ). Patient was hospitalized and became disabled.

6100778-5 | Melaena, Neutropenia
Adverse event was reported on Feb 23, 2009 by a Male patient taking Mopral (View Usage) (Dosage: ) was diagnosed with thrombocytopenia and. Location: FRANCE , weighting 7.05 lb, Patient had the following side effects: melaena, neutropenia. During the same period patient was treated with FERROSTRANE (View Ferrostrane Review and Ferrostrane Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN K (View Vitamin K Review and Vitamin K Label ). Patient was hospitalized.

6021896-6 | Asthenia, Metabolic Acidosis, Pyrexia, Respiratory Alkalosis, Tachypnoea, Vomiting
on Dec 24, 2008 Male patient from FRANCE , child 9 years of age, weighting 66.14 lb, was diagnosed with osteomyelitis chronic and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: asthenia, metabolic acidosis, pyrexia, respiratory alkalosis, tachypnoea, vomiting. Mopral dosage: . During the same period patient was treated with SALAZOPYRINE (View Salazopyrine Review and Salazopyrine Label ), PROFENID (View Profenid Review and Profenid Label ), NAPROXEN SODIUM (View Naproxen Sodium Review and Naproxen Sodium Label ), INDOCIN (View Indocin Review and Indocin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6017227-8 | Asthenia, Metabolic Acidosis, Pyrexia, Respiratory Alkalosis, Tachypnoea, Vomiting
on Dec 19, 2008 Male patient from FRANCE , child 9 years of age, weighting 66.14 lb, was diagnosed with obesity (What is obesity?) and was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, metabolic acidosis, pyrexia, respiratory alkalosis, tachypnoea, vomiting. Mopral dosage: . During the same period patient was treated with SALAZOPYRINE (View Salazopyrine Review and Salazopyrine Label ), PROFENID (View Profenid Review and Profenid Label ), NAPROXEN SODIUM (View Naproxen Sodium Review and Naproxen Sodium Label ), INDOCIN (View Indocin Review and Indocin Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

5968273-1 | Peripheral Sensorimotor Neuropathy
Patient was taking Mopral (View Usage). Patient had the following side effects: peripheral sensorimotor neuropathy on Nov 18, 2008 from FRANCE Additional patient health information: Male patient , 71 years of age, . Mopral dosage: .

5910682-0 | International Normalised Ratio Increased, Microcytic Anaemia, Overdose
Adverse event was reported on Sep 30, 2008 by a Female patient taking Mopral (View Usage) (Dosage: ) . Location: FRANCE , 75 years of age, After Mopral was administered, patient had the following side effects: international normalised ratio increased, microcytic anaemia, overdose. During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), PREVISCAN (View Previscan Review and Previscan Label ), SELOKEN (View Seloken Review and Seloken Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

5860286-3 | Renal Failure Acute
on Aug 18, 2008 Female patient from FRANCE , 73 years of age, was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Mopral dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5842020-6 | Bezoar
on Aug 07, 2008 Female patient from FRANCE , 79 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, pancreatic fistula, pruritus, constipation (What is constipation?) and was treated with Mopral (View Usage). Patient had the following side effects: bezoar. Mopral dosage: . During the same period patient was treated with OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CHOLESTYRAMINE (View Cholestyramine Review and Cholestyramine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5838573-4 | Ischaemic Stroke, Pneumonia Aspiration
Patient was taking Mopral (View Usage). After Mopral was administered, patient had the following side effects: ischaemic stroke, pneumonia aspiration on Aug 04, 2008 from FRANCE Additional patient health information: Male patient , 99 years of age, . Mopral dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AMLOR (View Amlor Review and Amlor Label ), ADANCOR (View Adancor Review and Adancor Label ), VASTAREL (View Vastarel Review and Vastarel Label ), IMOVANE (View Imovane Review and Imovane Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5838529-1 | Premature Baby, Pulmonary Artery Stenosis Congenital, Transposition Of The Great Vessels, Tricuspid Valve Incompetence, Ventricular Hypoplasia
Adverse event was reported on Jul 30, 2008 by a Male patient taking Mopral (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , weighting 4.41 lb, Patient experienced the following unwanted or unexpected effects: premature baby, pulmonary artery stenosis congenital, transposition of the great vessels, tricuspid valve incompetence, ventricular hypoplasia. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), DEDROGYL (View Dedrogyl Review and Dedrogyl Label ), ARAVA (View Arava Review and Arava Label ). Patient was hospitalized and became disabled.

5828552-5 | Fall, Hyponatraemia, Oedema Peripheral, Off Label Use
on Jul 24, 2008 Female patient from FRANCE , weighting 178.6 lb, was diagnosed with pollakiuria, cardiac failure, hypertension and was treated with Mopral (View Usage). Patient had the following side effects: fall (What is fall?), hyponatraemia, oedema peripheral, off label use. Mopral dosage: . During the same period patient was treated with MINIRIN (View Minirin Review and Minirin Label ), LASIX (View Lasix Review and Lasix Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VASTAREL (View Vastarel Review and Vastarel Label ), OROCAL D3 (View Orocal D3 Review and Orocal D3 Label ), TEMESTA (View Temesta Review and Temesta Label ).

5828528-8 | Peripheral Sensorimotor Neuropathy
on Jul 24, 2008 Male patient from FRANCE , 71 years of age, was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: peripheral sensorimotor neuropathy. Mopral dosage: .

5761257-8 | Polyneuropathy
Patient was taking Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: polyneuropathy on May 28, 2008 from FRANCE Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with hiatus hernia and. Mopral dosage: 20 Mg Per Day Three Days Out Of Four.

5759810-0 | Foetal Growth Retardation, Inguinal Hernia, Premature Baby
Adverse event was reported on May 27, 2008 by a Male patient taking Mopral (View Usage) (Dosage: ) was diagnosed with abdominal pain upper and. Location: FRANCE , weighting 3.75 lb, Patient had the following side effects: foetal growth retardation, inguinal hernia, premature baby.

5758833-5 | Arthralgia, Back Pain, Exophthalmos, Fatigue, Headache, Immunodeficiency, Musculoskeletal Stiffness, Vomiting
on May 27, 2008 Female patient from FRANCE , 15 years of age, was diagnosed with hiatus hernia and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: arthralgia, back pain (What is back pain?), exophthalmos, fatigue, headache (What is headache?), immunodeficiency, musculoskeletal stiffness, vomiting. Mopral dosage: . During the same period patient was treated with REVAXIS (View Revaxis Review and Revaxis Label ). Patient was hospitalized and became disabled.

5582937-3 |
on Jan 03, 2008 Male patient from FRANCE , weighting 12.79 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Mopral (View Usage). . Mopral dosage: . During the same period patient was treated with PROPULSID (View Propulsid Review and Propulsid Label ), MOTILIUM (View Motilium Review and Motilium Label ).

5579413-0 | Blood Potassium Decreased, Confusional State, Fatigue, Gastrointestinal Candidiasis, Hypersensitivity, Pain, Photosensitivity Reaction, Urticaria
Patient was taking Mopral (View Usage). Patient had the following side effects: blood potassium decreased, confusional state, fatigue, gastrointestinal candidiasis, hypersensitivity, pain (What is pain?), photosensitivity reaction, urticaria on Dec 26, 2007 from BELGIUM Additional patient health information: Female patient , weighting 106.5 lb, . Mopral dosage: . During the same period patient was treated with ESTROGEL (View Estrogel Review and Estrogel Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

5537489-0 | Hepatic Function Abnormal, Hepatitis Cholestatic, Pancreatic Enzymes Increased, Pelvic Fluid Collection, Pleural Effusion, Pyrexia
Adverse event was reported on Dec 04, 2007 by a Female patient taking Mopral (View Usage) (Dosage: ) was diagnosed with sciatica (What is sciatica?) and. Location: FRANCE , 41 years of age, After Mopral was administered, patient had the following side effects: hepatic function abnormal, hepatitis cholestatic, pancreatic enzymes increased, pelvic fluid collection, pleural effusion, pyrexia. During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), FELDENE (View Feldene Review and Feldene Label ). Patient was hospitalized.

5530678-0 | Haemolytic Anaemia
on Nov 26, 2007 Male patient from FRANCE , 69 years of age, was diagnosed with dyspepsia and was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Mopral dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLUPRED (View Solupred Review and Solupred Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ). Patient was hospitalized.

5530677-9 | Mouth Haemorrhage, Thrombocytopenic Purpura
on Nov 27, 2007 Female patient from FRANCE , weighting 103.6 lb, was diagnosed with gastrooesophageal reflux disease, polyarthritis, hypercholesterolaemia and was treated with Mopral (View Usage). Patient had the following side effects: mouth haemorrhage, thrombocytopenic purpura. Mopral dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DIFFU K (View Diffu K Review and Diffu K Label ), LODALES (View Lodales Review and Lodales Label ), DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ). Patient was hospitalized.

5529583-5 | Blood Sodium Decreased, Confusional State, Fatigue, Gastrointestinal Candidiasis, Hypersensitivity, Pain, Photosensitivity Reaction, Urticaria
Patient was taking Mopral (View Usage). After Mopral was administered, patient had the following side effects: blood sodium decreased, confusional state, fatigue, gastrointestinal candidiasis, hypersensitivity, pain (What is pain?), photosensitivity reaction, urticaria on Nov 22, 2007 from BELGIUM Additional patient health information: Female patient , weighting 106.5 lb, . Mopral dosage: . During the same period patient was treated with ESTROGEL (View Estrogel Review and Estrogel Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5442610-9 | Type 1 Diabetes Mellitus
Adverse event was reported on Aug 28, 2007 by a Female patient taking Mopral (View Usage) (Dosage: ) . Location: FRANCE , 25 years of age, Patient experienced the following unwanted or unexpected effects: type 1 diabetes mellitus. During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

5442607-9 | Agranulocytosis, Dermatitis Exfoliative, Hepatitis, Hypotension, Pyrexia, Renal Failure Acute, Thrombocytopenia
on Aug 28, 2007 Female patient from FRANCE , 45 years of age, was diagnosed with gastroduodenal ulcer and was treated with Mopral (View Usage). Patient had the following side effects: agranulocytosis, dermatitis exfoliative, hepatitis (What is hepatitis?), hypotension, pyrexia, renal failure acute, thrombocytopenia. Mopral dosage: . During the same period patient was treated with OXACILLIN (View Oxacillin Review and Oxacillin Label ), OFLOCET (View Oflocet Review and Oflocet Label ), LOVENOX (View Lovenox Review and Lovenox Label ), GENTALLINE (View Gentalline Review and Gentalline Label ), RIFADIN (View Rifadin Review and Rifadin Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ). Patient was hospitalized.

5436950-7 | Anaemia, Peritoneal Haemorrhage
on Aug 22, 2007 Male patient from FRANCE , weighting 189.6 lb, was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: anaemia, peritoneal haemorrhage. Mopral dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), AMIODARONE (200 Mg Daily For Five Days Per Week) (View Amiodarone Review and Amiodarone Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), TAHOR (View Tahor Review and Tahor Label ), CIFLOX (View Ciflox Review and Ciflox Label ). Patient was hospitalized.

5241734-9 | Hyperthyroidism
Patient was taking Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: hyperthyroidism on Feb 14, 2007 from FRANCE Additional patient health information: Male patient , 83 years of age, was diagnosed with cardiomyopathy (What is cardiomyopathy?), haemangioma, essential hypertension, ischaemic cardiomyopathy and. Mopral dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), TEMGESIC (View Temgesic Review and Temgesic Label ), MICARDIS (View Micardis Review and Micardis Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ). Patient was hospitalized.

5237801-6 | Anaemia Haemolytic Autoimmune
Adverse event was reported on Feb 01, 2007 by a Female patient taking Mopral (View Usage) (Dosage: ) . Location: FRANCE , 82 years of age, weighting 97.00 lb, Patient had the following side effects: anaemia haemolytic autoimmune. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), LANZOR (View Lanzor Review and Lanzor Label ), LASIX (View Lasix Review and Lasix Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5099786-5 | Dyspepsia, Epididymitis, Nephritis Interstitial, Renal Failure Acute
on Aug 03, 2006 Male patient from FRANCE , 76 years of age, was diagnosed with dyspepsia and was treated with Mopral (View Usage). After Mopral was administered, patient had the following side effects: dyspepsia, epididymitis, nephritis interstitial, renal failure acute. Mopral dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ), PREVISCAN (View Previscan Review and Previscan Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), CIPRALAN (View Cipralan Review and Cipralan Label ), MOTILIUM (View Motilium Review and Motilium Label ). Patient was hospitalized.

5094154-4 | Condition Aggravated, Gamma-glutamyltransferase Increased, Haemolytic Anaemia, Macrocytosis
on Aug 22, 2006 Female patient from FRANCE , 32 years of age, weighting 125.7 lb, was treated with Mopral (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gamma-glutamyltransferase increased, haemolytic anaemia, macrocytosis. Mopral dosage: . During the same period patient was treated with EFFERALGAN CODEINE (View Efferalgan Codeine Review and Efferalgan Codeine Label ), SUBUTEX (View Subutex Review and Subutex Label ). Patient was hospitalized.

5093970-2 | Anaemia, Thrombocytopenia
Patient was taking Mopral (View Usage). Patient had the following side effects: anaemia, thrombocytopenia on Aug 22, 2006 from FRANCE Additional patient health information: Female patient , 55 years of age, weighting 149.9 lb, was diagnosed with gastrointestinal haemorrhage, embolism venous, major depression, mitral valve incompetence and. Mopral dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DEROXAT (View Deroxat Review and Deroxat Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), EFFEXOR (View Effexor Review and Effexor Label ), XANAX (View Xanax Review and Xanax Label ), IMOVANE (View Imovane Review and Imovane Label ), DAFALGAN CODEINE (View Dafalgan Codeine Review and Dafalgan Codeine Label ). Patient was hospitalized.